Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-24
1996-03-05
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514450, 549350, 549366, A61K 31335, A61K 3136, C07D31920
Patent
active
054968470
ABSTRACT:
Certain aminomethyl-benzodioxanes and benzopyrans are useful serotonergic agents. They possess anxiolytic properties with few of the side effects often associated with dopaminergic agents.
REFERENCES:
patent: 2979508 (1961-04-01), Janssen
patent: 3717634 (1973-02-01), Wu et al.
patent: 3965180 (1976-06-01), Lednicer
patent: 4831034 (1989-05-01), Barreau et al.
patent: 4933453 (1990-06-01), Hrib et al.
patent: 4954502 (1990-09-01), Smith et al.
patent: 4957921 (1990-09-01), Caprathe et al.
patent: 4975445 (1990-12-01), Caprathe et al.
patent: 5168099 (1992-12-01), Iwata et al.
J. S. New, "The Discovery and Development of Buspirone: a New Approach to the Treatment of Anxiety", Medicinal Research Reviews, 10, No. 3, (1990) pp. 283-326.
Catt John D.
Mattson Ronald J.
Bristol-Myers Squibb Co.
Chan Nicky
Nolan Sandra M.
LandOfFree
Aminomethyl-benzodioxane and benzopyran serotonergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminomethyl-benzodioxane and benzopyran serotonergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminomethyl-benzodioxane and benzopyran serotonergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413208